Navigation Links
Stryker Hip Recall: Bernstein Liebhard LLP Notes Scheduling of Initial Conference in New Jersey Litigation
Date:2/9/2013

New York, New York (PRWEB) February 09, 2013

Lawsuits stemming from the recent Stryker hip recall are moving forward in a consolidated litigation established in New Jersey Superior Court, Bergen County, Bernstein Liehbhard LLP reports. According to court documents, Judge Brian R. Martinotti has scheduled the litigation’s initial conference for February 20, 2013 at 10:00 a.m. (In re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296 (N.J. Super. Ct., Bergen Cty.)

“We continue to hear from patients impacted by the Stryker Rejuvenate recall and look forward to the commencement of this litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently investigating Stryker hip recall lawsuits on behalf of individuals impacted by the Stryker Rejuvenate and ABG II Modular-Neck Hip stem recall.

Stryker Hip Recall
Stryker recalled its Rejuvenate and ABG II modular neck-stems on July 6, 2012, due to a potential for fretting and corrosion at the modular-neck junction that may result in pain, swelling and adverse local tissue reactions. The Stryker consolidated litigation in New Jersey was established last month, after plaintiffs in Stryker hip recall lawsuits petitioned the New Jersey Supreme Court in September. All of the claims pending in the litigation allege Stryker marketed a defective product and failed to warn patients about the risks associated with the Rejuvenate and ABG II stems.

In its most recent recall update, Stryker advised patients fitted with the recalled components to undergo metal ion testing and cross sectional imaging, even if they are not experiencing symptoms of a failing hip implant. According to the company, some individuals affected by the Stryker hip recall have experienced high levels of metal ions in their blood and/or adverse local tissue reactions, even in the absence of symptoms.* Stryker also announced that it has retained Broadspire Services, Inc., a third-party claims administrator, to work directly with patients to manage medical claims and address out-of-pocket costs relating to the Stryker Rejuvenate recall.** Bernstein Liebhard LLP is advising patients that they should consider speaking with an attorney before they begin the Broadspire Stryker claims process, as any information they disclose to a Broadspire representative or in the course of the claims process could be used as evidence in their Stryker hip recall lawsuit.

Individuals who have suffered hip implant failures, metal poisoning, pain, or revision surgery allegedly due to the recalled Rejuvenate and ABG II components may be entitled to file a Stryker hip recall lawsuit seeking compensation for their medical care, pain and suffering, and other damages. A wealth of information is available at Bernstein Liebhard LLP’s Stryker hip recall website. Free lawsuit evaluations can be obtained by calling 877-779-1414.

*literature.ortho.stryker.com/files/REJUV_COM_23.pdf
**literature.ortho.stryker.com/files/REJUV_COM_22.pdf

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/stryker-hip-recall/stryker-rejuvenate-recall/prweb10413059.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. US Drug Watchdog Has Added Wright, Stryker, Biomet, and Zimmer To Their Initiative For All Metal Hip Implant Failures Victims & Offers Them The Names Of The Best Lawyers
2. US Drug Watchdog Now Offers DePuy, Stryker, Biomet, Zimmer, and Wright All Metal Hip Implant Failure Victims the Names of the Best Law Firms-Don't Get Left Holding the Bag
3. US Drug Watchdog Now Offers Recipients Of A DePuy, Wright, Stryker, Biomet or Zimmer Metal on Metal Hip Implant The Names of the Best Law Firms If Their Hip Has Failed
4. US Drug Watchdog Now Urges All Zimmer, Stryker, Biomet, Wright and DePuy Metal Hip Implant Recipients to Get Blood Tests
5. Stryker Hip Recall Lawsuits Being Evaluated by Bernstein Liebhard LLP, Following Recall of Stryker Rejuvenate and ABG II Modular Neck Stems
6. US Drug Watchdog Now Urges All Zimmer Stryker, Biomet, Wright and DePuy All Metal Hip Implant Recipients to Get A Blood Test For A Failure-Don't Get Left Holding the Bag
7. d’Oliveira & Associates Issues Webpage With Current Information On Stryker Hip Implant Lawsuits
8. DePuy ASR Hip Recall: Status Conference Held in Federal DePuy ASR Hip Litigation in Ohio
9. DePuy ASR Hip Recall: Bernstein Liebhard Notes British Call for Criminal Inquiry Following Revelations in U.S. DePuy ASR Trial
10. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
11. Cell Phone Radiation Lawsuit Update: ICEMS Position Paper Supports Italian Supreme Court Ruling on Cell Phones and Brain Tumors, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: